35th Hemophilia Symposium Hamburg 2004: Epidemiology;Risk of Infections and Inhibitors in Hemophilia; Chronic lic Synovitis and Long-term Results of Orthopedic Treatment;Laboratory Diagnostics:Coagulation Factors; Inhibitors, Monitoring;Pediatric Hemostaseology;Free Lectures

Front Cover
Inge Scharrer, Wolfgang Schramm
Springer Science & Business Media, May 24, 2006 - Medical - 270 pages
0 Reviews
Motion analysis as introduced 2 years ago on a national basis effectively identifies individual functional disorders and provides a means for describing them on the basis of a score. Individual therapy planning is possible. More treatment tends to produce better function scores and thus helps to lower the strain on the joint. Further study is required in order to determine whether this reduces the incidence of bleeding. Knee function is age-dependent. Height, weight and sporting activity seem to be influencing factors.Demeanor,pain,fatigue and parental motivation do not seem to have an impact. The roll-and-glide pattern is not age-dependent and probably shows functional abnormalities of the knee.Functional benchmarking of the sites is possible but d- ficult because each site selects the children differently.Age differences also render an overall assessment difficult. Some sites performed negative screening so as to only test children with more severe problems,while other sites performed no such selection.In other sites,the only children to show up for motion analysis were those with well informed parents and who are always involved in all the other activities on offer too.
 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

Hemophilia Registry of the Medical Committee of the Swiss Hemophilia
13
b Inhibitors in Hemophilia
19
nvCJD and Blood Products in the
29
18 Months postLicensure
38
R Klamroth Ch Heinrichs S Gottstein R Koch 49
52
Epitope Mapping during FVIII Inhibitor Elimination with Rituximab Reveals
66
Lack of Factor VIII Expression Represents a Novel Mechanism Leading
81
Pediatric Hemostaseology
85
The Clinical Course of two Patients Receiving High Dose Factor VIII
150
Immunosuppressive Treatment in Acquired von Willebrands Syndrome
165
Testing Factor VIII Activity by Using the Chromogenic Assay in Carriers
179
Successful Therapy with anti CD20 Monoclonal Antibody Rituximab
187
Successful Major Surgery with Minimal Dosage of rFVIIa in a Hemophilia
194
A Retrospective Study in Germany
201
The Frequency of Venous Thromboembolism in Women with FV Leiden
209
Hemophilia Patients and Prothrombotic Gene Mutation
219

Decreased Clotting Factor Activity VIII IX XI and XII due to Inhibitors with
102
Mutation Analysis in Hereditary Angioedema Identifies Patients at Risk
120
The ABCs of Hemophilia
134
The Long Journey to Being Diagnosed as a Carrier of Hemophilia A
136
gAla82Gly Represents a Common Fibrinogen Chain Variant in Caucasians
221
e Miscellaneous
235
A Hlusˇí V Krcˇová P Novák L Slavík
259
Copyright

Other editions - View all

Common terms and phrases

Bibliographic information